CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 414 of 865
Non-Antibody Products
Page 414 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Itraconazole-d5 | An internal standard for the quantification of itraconazole by GC- or LC-MS | 1 mg | 25219-1 | More Info |
| Itraconazole-d5 | An internal standard for the quantification of itraconazole by GC- or LC-MS | 500 µg | 25219-500 | More Info |
| ITSA1 | A cell-permeable suppressor of TSA action, reducing TSA-induced acetylatio… | 10 mg | 18681-10 | More Info |
| ITSA1 | A cell-permeable suppressor of TSA action, reducing TSA-induced acetylatio… | 100 mg | 18681-100 | More Info |
| ITSA1 | A cell-permeable suppressor of TSA action, reducing TSA-induced acetylatio… | 25 mg | 18681-25 | More Info |
| ITSA1 | A cell-permeable suppressor of TSA action, reducing TSA-induced acetylatio… | 50 mg | 18681-50 | More Info |
| IT1t (hydrochloride) | A CXCR4 antagonist (IC50s = 8 and 11 nM for the human and rat receptors, r… | 10 mg | 28434-10 | More Info |
| IT1t (hydrochloride) | A CXCR4 antagonist (IC50s = 8 and 11 nM for the human and rat receptors, r… | 25 mg | 28434-25 | More Info |
| IT1t (hydrochloride) | A CXCR4 antagonist (IC50s = 8 and 11 nM for the human and rat receptors, r… | 5 mg | 28434-5 | More Info |
| Iturin A-2 | A cyclic lipopeptide with diverse biological activities; is active against… | 1 mg | 38911-1 | More Info |
| IU1 | A reversible, small molecule inhibitor of USP14 deubiquitination (IC50 = 4… | 10 mg | 10617-10 | More Info |
| IU1 | A reversible, small molecule inhibitor of USP14 deubiquitination (IC50 = 4… | 100 mg | 10617-100 | More Info |
| IU1 | A reversible, small molecule inhibitor of USP14 deubiquitination (IC50 = 4… | 5 mg | 10617-5 | More Info |
| IU1 | A reversible, small molecule inhibitor of USP14 deubiquitination (IC50 = 4… | 50 mg | 10617-50 | More Info |
| IU1-47 | An inhibitor of USP14 (IC50 = 0.6 µM); selective for USP14 over USP5… | 10 mg | 34095-10 | More Info |
| IU1-47 | An inhibitor of USP14 (IC50 = 0.6 µM); selective for USP14 over USP5… | 25 mg | 34095-25 | More Info |
| IU1-47 | An inhibitor of USP14 (IC50 = 0.6 µM); selective for USP14 over USP5… | 5 mg | 34095-5 | More Info |
| Ivabradine-d3 (hydrochloride) | An internal standard for the quantification of ivabradine by GC- or LC-MS | 1 mg | 25711-1 | More Info |
| Ivabradine-d3 (hydrochloride) | An internal standard for the quantification of ivabradine by GC- or LC-MS | 500 µg | 25711-500 | More Info |
| Ivabradine (hydrochloride) | An HCN channel blocker; blocks If in HEK293 cells expressing mouse HCN1, h… | 10 mg | 15868-10 | More Info |
| Ivabradine (hydrochloride) | An HCN channel blocker; blocks If in HEK293 cells expressing mouse HCN1, h… | 100 mg | 15868-100 | More Info |
| Ivabradine (hydrochloride) | An HCN channel blocker; blocks If in HEK293 cells expressing mouse HCN1, h… | 250 mg | 15868-250 | More Info |
| Ivabradine (hydrochloride) | An HCN channel blocker; blocks If in HEK293 cells expressing mouse HCN1, h… | 50 mg | 15868-50 | More Info |
| Ivacaftor | A CFTR potentiator; increases the forskolin-induced CFTR-mediated epitheli… | 1 mg | 15145-1 | More Info |
| Ivacaftor | A CFTR potentiator; increases the forskolin-induced CFTR-mediated epitheli… | 10 mg | 15145-10 | More Info |
| Ivacaftor | A CFTR potentiator; increases the forskolin-induced CFTR-mediated epitheli… | 5 mg | 15145-5 | More Info |
| Ivacaftor | A CFTR potentiator; increases the forskolin-induced CFTR-mediated epitheli… | 50 mg | 15145-50 | More Info |
| Ivacaftor-d19 | An internal standard for the quantification of ivacaftor by GC- or LC-MS | 1 mg | 28539-1 | More Info |
| Ivermectin | A mixture of ivermectin B1a and ivermectin B1b | 1 g | 35518-1 | More Info |
| Ivermectin | A mixture of ivermectin B1a and ivermectin B1b | 250 mg | 35518-250 | More Info |
| Ivermectin | A mixture of ivermectin B1a and ivermectin B1b | 5 g | 35518-5 | More Info |
| Ivermectin | A mixture of ivermectin B1a and ivermectin B1b | 500 mg | 35518-500 | More Info |
| Ivermectin B1a | The main component (>80%) of ivermectin; binds to glutamate-gated chloride… | 25 mg | 18768-25 | More Info |
| Ivermectin B1a | The main component (>80%) of ivermectin; binds to glutamate-gated chloride… | 5 mg | 18768-5 | More Info |
| Ivermectin B1a aglycone | An acid degradation product produced by hydrolysis of the disaccharide uni… | 1 mg | 19442-1 | More Info |
| Ivermectin B1a aglycone | An acid degradation product produced by hydrolysis of the disaccharide uni… | 5 mg | 19442-5 | More Info |
| Ivermectin B1a monosaccharide | Produced by selective hydrolysis of the terminal saccharide unit of iverme… | 10 mg | 19443-10 | More Info |
| Ivermectin B1a monosaccharide | Produced by selective hydrolysis of the terminal saccharide unit of iverme… | 5 mg | 19443-5 | More Info |
| Ivermectin B1b | The minor component (<20%) of ivermectin; binds to glutamate-gated chlorid… | 2.5 mg | 23824-25 | More Info |
| Ivermectin B1b | The minor component (<20%) of ivermectin; binds to glutamate-gated chlorid… | 500 µg | 23824-500 | More Info |
| Ivermectin-d2 | An internal standard for the quantification of ivermectin by GC- or LC-MS | 1 mg | 35345-1 | More Info |
| IWP-12 | A PORCN inhibitor; inhibits cell-autonomous Wnt signaling (IC50 = 15 nM), | 1 mg | 22729-1 | More Info |
| IWP-12 | A PORCN inhibitor; inhibits cell-autonomous Wnt signaling (IC50 = 15 nM), | 10 mg | 22729-10 | More Info |
| IWP-12 | A PORCN inhibitor; inhibits cell-autonomous Wnt signaling (IC50 = 15 nM), | 25 mg | 22729-25 | More Info |
| IWP-12 | A PORCN inhibitor; inhibits cell-autonomous Wnt signaling (IC50 = 15 nM), | 5 mg | 22729-5 | More Info |
| IWP-2 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 2… | 1 mg | 13951-1 | More Info |
| IWP-2 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 2… | 10 mg | 13951-10 | More Info |
| IWP-2 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 2… | 25 mg | 13951-25 | More Info |
| IWP-2 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 2… | 5 mg | 13951-5 | More Info |
| IWP-3 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 4… | 1 mg | 13953-1 | More Info |
| IWP-3 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 4… | 10 mg | 13953-10 | More Info |
| IWP-3 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 4… | 25 mg | 13953-25 | More Info |
| IWP-3 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 4… | 5 mg | 13953-5 | More Info |
| IWP-4 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 2… | 1 mg | 13954-1 | More Info |
| IWP-4 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 2… | 10 mg | 13954-10 | More Info |
| IWP-4 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 2… | 25 mg | 13954-25 | More Info |
| IWP-4 | An inhibitor of Wnt production that impairs Wnt pathway activity (IC50 = 2… | 5 mg | 13954-5 | More Info |
| IWP-L6 | A potent inhibitor of PORCN (EC50 = 0.5 nM); displays high stability in hu… | 10 mg | 15243-10 | More Info |
| IWP-L6 | A potent inhibitor of PORCN (EC50 = 0.5 nM); displays high stability in hu… | 5 mg | 15243-5 | More Info |
| IWP-L6 | A potent inhibitor of PORCN (EC50 = 0.5 nM); displays high stability in hu… | 50 mg | 15243-50 | More Info |
| IWP-O1 | A PORCN inhibitor; inhibits Wnt signaling in L-Wnt-STF cells (IC50 = 80 pM… | 10 mg | 38418-10 | More Info |
| IWP-O1 | A PORCN inhibitor; inhibits Wnt signaling in L-Wnt-STF cells (IC50 = 80 pM… | 25 mg | 38418-25 | More Info |
| IWP-O1 | A PORCN inhibitor; inhibits Wnt signaling in L-Wnt-STF cells (IC50 = 80 pM… | 5 mg | 38418-5 | More Info |
| IWP-2-V2 | A less potent IWP-2 derivative that has been used to determine which struc… | 1 mg | 13952-1 | More Info |
| IWP-2-V2 | A less potent IWP-2 derivative that has been used to determine which struc… | 10 mg | 13952-10 | More Info |
| IWP-2-V2 | A less potent IWP-2 derivative that has been used to determine which struc… | 25 mg | 13952-25 | More Info |
| IWP-2-V2 | A less potent IWP-2 derivative that has been used to determine which struc… | 5 mg | 13952-5 | More Info |
| IWR-1-endo | A potent inhibitor of the Wnt response, blocking a cell-based Wnt/β-c… | 10 mg | 13659-10 | More Info |
| IWR-1-endo | A potent inhibitor of the Wnt response, blocking a cell-based Wnt/β-c… | 25 mg | 13659-25 | More Info |
| IWR-1-endo | A potent inhibitor of the Wnt response, blocking a cell-based Wnt/β-c… | 5 mg | 13659-5 | More Info |
| IWR-1-endo | A potent inhibitor of the Wnt response, blocking a cell-based Wnt/β-c… | 50 mg | 13659-50 | More Info |
| IWR-1-exo | An ideal control for the inhibitor of Wnt response compound, IWR-1-endo | 10 mg | 13598-10 | More Info |
| IWR-1-exo | An ideal control for the inhibitor of Wnt response compound, IWR-1-endo | 25 mg | 13598-25 | More Info |
| IWR-1-exo | An ideal control for the inhibitor of Wnt response compound, IWR-1-endo | 5 mg | 13598-5 | More Info |
| IWR-1-exo | An ideal control for the inhibitor of Wnt response compound, IWR-1-endo | 50 mg | 13598-50 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile